Neuronetics, Inc. (NasdaqGM: STIM)
Health Care · Health Care Equipment & Supplies · US
$2.13
-0.23% today · -23.7% 1Y
Neuronetics, Inc. (NasdaqGM: STIM) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $162.30M and employs 658 people.
Over the last twelve months the share price has lost 23.7%, trading between 0.80 and 3.44.
Tweenvest scores Neuronetics, Inc. across four factors: quality 45/100, value 60/100, growth 88/100. Its strongest factor is growth.
STIM price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $162.30M
- Revenue (TTM)
- $155.10M
- P/E
- —
- EPS
- -0.44
- Dividend yield
- —
- Beta (5Y)
- 1.20
- 52-week high
- $3.44
- 52-week low
- $0.80
- Avg volume (3M)
- —
- Shares outstanding
- 76.20M
- Employees
- 658
- Next earnings
- —
About Neuronetics, Inc.
Neuronetics, Inc. functions as a medical technology enterprise with commercialized products, specializing in the creation, enhancement, and global distribution of solutions for individuals experiencing neurohealth conditions, both within the U.S. and abroad. The company's flagship product is the NeuroStar Advanced Therapy System, an in-office, non-surgical, and non-pharmaceutical treatment option available for adult patients diagnosed with major depressive disorder. This sophisticated system utilizes transcranial magnetic stimulation (TMS) to generate a pulsed magnetic field, similar in strength to an MRI, which subsequently induces electrical currents. These currents are specifically engineered to activate brain areas that are key to mood regulation. Neuronetics distributes its offerings directly to psychiatrists through its dedicated sales and client support personnel. Established in 2001, the company's corporate headquarters are situated in Malvern, Pennsylvania.
- ISIN
- US64131A1051
- Founded
- 2001
- Listed since
- Jun 28, 2018
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Suheung Co., Ltd.KOSE: A008490 | $167.74M | ₩20,250.00 | -0.74% |
| PW Medtech Group LimitedSEHK: 1358 | $165.67M | HK$0.91 | +2.25% |
| Inogen, Inc.NasdaqGS: INGN | $164.01M | $6.42 | +3.80% |
| Synthetica ADBUL: SYN | $163.52M | €48.00 | +5.26% |
| Jin Medical International Ltd.NasdaqCM: ZJYL | $161.57M | $2.13 | +3.40% |
| Medinice S.A.WSE: ICE | $161.39M | zł57.70 | -4.63% |
| DuChemBIO Co.,Ltd.KOSDAQ: A176750 | $159.79M | ₩7,570.00 | +3.84% |
| Boditech Med Inc.KOSDAQ: A206640 | $158.08M | ₩9,790.00 | +0.41% |
Figures last refreshed Oct 11, 2026.